Radiation therapy for neovascular age-related macular degeneration

Clinical Ophthalmology

Volumn 5, Issue 1, 2011, Pages 57-63

  Petrarca, Robert ^a   Jackson, Timothy L ^a  

^a KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Anti VEGF; Epimacular brachytherapy; Neovascular; Radiation therapy; Stereotactic radiosurgery; Wet age related macular degeneration

Indexed keywords

RANIBIZUMAB; STRONTIUM 90; VASCULOTROPIN ANTIBODY; YTTRIUM 90;

ARTICLE; BRACHYTHERAPY; CELL PROLIFERATION; CILIARY DISK; COLON CANCER; ELECTRON THERAPY; ENDOTHELIUM CELL; FEASIBILITY STUDY; FIBROBLAST; HUMAN; INFLAMMATORY CELL; IONIZING RADIATION; RADIATION BEAM; RADIATION DOSE; RADIOTHERAPY; RETINA MACULA AGE RELATED DEGENERATION; RETINA NEOVASCULARIZATION; STEREOTACTIC RADIOSURGERY; TELETHERAPY; THERAPY EFFECT; VITRECTOMY;

EID: 79251562483     PISSN: 11775467     EISSN: 11775483     Source Type: Book Series    
DOI: 10.2147/OPTH.S16444     Document Type: Article

References (30)

1. Fletcher A, Donoghue M, Owen C. Low vision services for people with age-related macular degeneration in the UK: a review of services needed and provision 2001. Macular Disease Society Report.
2. NICE: HTA Ranibizumab and pegaptanib for the treatment of AMD. Final scope: www.nice.org.uk; 2006. Accessed Nov 18, 2010.
3. Ferris FL III, Fine SL, Hyman L. Age-related macular degeneration and blindness due to neovascular maculopathy. Arch Ophthalmol. 1984; 102(11):1640-1642.
4. Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355(14): 1419-1431.
5. Brown DM, Kaiser PK, Michels M, et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med. 2006;355(14):1432-1444.
6. Spaide R. Ranibizumab according to need: a treatment for age-related macular degeneration. Am J Ophthalmol. 2007;143(4):679-680.
7. Kirwan JF, Constable PH, Murdoch IE, Khaw PT. Beta irradiation: new uses for an old treatment: a review. Eye. 2003;17(2):207-215.
8. Barnhard HJ. Supervoltage therapy comes of age. N Engl J Med. 1958; 258(6):275-277.
9. Chakravarthy U, MacKenzie G. External beam radiotherapy in exudative age-related macular degeneration: a pooled analysis of phase I data. Br J Radiol. 2000;73(867):305-313.
10. Jaakkola A, Heikkonen J, Tommila P, Laatikainen L, Immonen I. Strontium plaque brachytherapy for exudative age-related macular degeneration: three-year results of a randomized study. Ophthalmology. 2005;112(4):567-573.
11. Evans JR, Sivagnanavel V, Chong V. Radiotherapy for neovascular agerelated macular degeneration. Cochrane Database Syst Rev. 2010(5): CD004004.
12. Rokni SH, Fassò A, Liu JC. Operational radiation protection in highenergy physics accelerators. Radiat Prot Dosimetry. 2009;137(1-2): 3-17.
13. BW. Comparison of eff icacy of proton beam and 90Sr/90Y beta radiation in treatment of exudative age-related macular degeneration. NeoVista Inc., 47865 Fremont Blvd., Fremont, CA, 94538; 2008.
14. Willett CG, Boucher Y, di Tomaso E, et al. Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Nat Med. 2004;10(2):145-147.
15. Senan S, Smit EF. Design of clinical trials of radiation combined with antiangiogenic therapy. Oncologist. 2007;12(4):465-477.
16. Avila MP, Farah ME, Santos A, et al. Twelve-month safety and visual acuity results from a feasibility study of intraocular, epiretinal radiation therapy for the treatment of subfoveal CNV secondary to AMD. Retina. 2009;29(2):157-169.
17. Ávila MP, Farah ME, Santos A, Duprat JP, Woodward BW, Nau J. Twelve-month short-term safety and visual-acuity results from a multicentre prospective study of epiretinal strontium-90 brachytherapy with bevacizumab for the treatment of subfoveal choroidal neovascularisation secondary to age-related macular degeneration. Br J Ophthalmol. 2009;93(3):305-309.
18. Parsons JT, Bova FJ, Fitzgerald CR, Mendenhall WM, Million RR. Radiation retinopathy after external-beam irradiation: analysis of timedose factors. Int J Radiat Oncol Biol Phys. 1994;30(4):765-773.
19. Boozalis GT, Schachat AP, Green WR. Subretinal neovascularization from the retina in radiation retinopathy. Retina. 1987;7(3):156-161.
20. Gordon KB, Char DH, Sagerman RH. Late effects of radiation on the eye and ocular adnexa. Int J Radiat Oncol Biol Phys. 1995;31(5): 1123-1139.
21. Hanlon J, Lee C, Chell E, et al. Kilovoltage stereotactic radiosurgery for age-related macular degeneration: assessment of optic nerve dose and patient effective dose. Med Phys. 2009;36(8):3671-3681.
22. Finger PT, Berson A, Ng T, Szechter A. Ophthalmic plaque radiotherapy for age-related macular degeneration associated with subretinal neovascularization. Am J Ophthalmol. 1999;127(2):170-177.
23. Timke C, Zieher H, Roth A, et al. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy. Clin Cancer Res. 2008; 14(7):2210-2219.
24. Stefansson E, Landers MB 3rd, Wolbarsht ML. Increased retinal oxygen supply following pan-retinal photocoagulation and vitrectomy and lensectomy. Trans Am Ophthalmol Soc. 1981;79:307-334.
25. LM. Oxygen therapy and intraocular oxygenation. Trans Am Ophthalmol Soc. 1987;85:407-437.
26. Hashimoto E, Hirakata A, Hotta K, Shinoda K, Miki D, Hida T. Unusual macular retinal detachment associated with vitreomacular traction syndrome. Br J Ophthalmol. 1998;82(3):326.
27. Nordsmark M, Overgaard M, Overgaard J. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother Oncol. 1996;41(1):31-39.
28. Brizel DM, Scully SP, Harrelson JM, et al. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res. 1996;56(5):941-943.
29. Moshfeghi DM, Kaiser PK, Gertner M. Stereotactic low-voltage x-ray irradiation for age-related macular degeneration. Br J Ophthalmol. 2010 Sep 18. [Epub ahead of print].
30. Lee C, Chell E, Gertner M, et al. Dosimetry characterization of a multibeam radiotherapy treatment for age-related macular degeneration. Med Phys. 2008;35(11):5151-5160.